XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Revenues        
Total revenues $ 84,730 $ 84,622 $ 167,977 $ 170,855
Costs of revenue (exclusive of amortization and depreciation)        
Total costs of revenue (exclusive of amortization and depreciation) 43,342 44,133 85,103 88,310
Product development 8,207 8,769 18,894 17,121
Sales and marketing 7,815 8,132 14,408 15,089
General and administrative 18,878 19,057 38,274 33,510
Amortization 9,107 5,840 14,975 11,341
Depreciation 400 597 800 1,095
Total expenses 87,749 86,528 172,454 166,466
Operating income (loss) (3,019) (1,906) (4,477) 4,389
Other income (expense):        
Other income 91 78 1,514 346
Interest expense (4,242) (2,664) (8,315) (5,334)
Total other expense (4,151) (2,586) (6,801) (4,988)
Loss before taxes (7,170) (4,492) (11,278) (599)
Income tax benefit (2,121) (1,655) (3,713) (846)
Net income (loss) $ (5,049) $ (2,837) $ (7,565) $ 247
Net income (loss) per common share—basic (in dollars per share) $ (0.34) $ (0.20) $ (0.51) $ 0.02
Net income (loss) per common share—diluted (in dollars per share) $ (0.34) $ (0.20) $ (0.51) $ 0.02
Weighted average shares outstanding used in per common share computations:        
Basic (in shares) 14,313 14,200 14,273 14,168
Diluted (in shares) 14,313 14,200 14,273 14,168
RCM        
Revenues        
Total revenues $ 54,108 $ 47,760 $ 107,146 $ 96,391
Costs of revenue (exclusive of amortization and depreciation)        
Total costs of revenue (exclusive of amortization and depreciation) 30,269 27,119 59,866 54,302
EHR        
Revenues        
Total revenues 30,622 36,862 60,831 74,464
Costs of revenue (exclusive of amortization and depreciation)        
Total costs of revenue (exclusive of amortization and depreciation) $ 13,073 $ 17,014 $ 25,237 $ 34,008